Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization
Linked Content This article is linked to Bock et al and Bantel et al papers. To view these articles visit https://doi.org/10.1111/apt.13578 and https://doi.org/10.1111/apt.13826.
Gespeichert in:
Veröffentlicht in: | Alimentary pharmacology & therapeutics 2017-01, Vol.45 (1), p.183-184 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 184 |
---|---|
container_issue | 1 |
container_start_page | 183 |
container_title | Alimentary pharmacology & therapeutics |
container_volume | 45 |
creator | He, Z.‐H. He, W.‐R. Wu, L.‐L. Zhao, C. Peng, N.‐F. Ahir, B.‐K. Lu, C.‐Y. |
description | Linked Content
This article is linked to Bock et al and Bantel et al papers. To view these articles visit https://doi.org/10.1111/apt.13578 and https://doi.org/10.1111/apt.13826. |
doi_str_mv | 10.1111/apt.13820 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1845817067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1922443998</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3880-6a03c9608d6ee4e1a63ad7a97f4cadf973082fc1ddb8e3fefbe33e1b7958a24f3</originalsourceid><addsrcrecordid>eNp1kc1u1DAURi3Uig6FBS-ALHVDF2n9k0lsdlVFAWmkshjW1o1zTV2SeLAdVcOKR-AZ-yR4mJZFpXpj6_ro6Or7CHnL2Rkv5xw2-YxLJdgLsuCyWVaCyeaALJhodCUUl0fkVUq3jLGmZeIlORKt5ozXakHyCnPG-IHabQ4_MEL20_3vP1xRSBRo58MIscxpcPQGN5CDxWGYB4jUQrR-Kv804veIKfkwUXDFRnOEKUEsTw8DtTc4Bhy7MPhfxR-m1-TQwZDwzcN9TL5dfVxffq5W15--XF6sKiuVYlUDTFrdMNU3iDVyaCT0LejW1RZ6p1vJlHCW932nUDp0HUqJvGv1UoGonTwm7_feTQw_Z0zZjD7t9ocJw5wMV_VS8bakUtCTJ-htmONUtjNcC1HXUmtVqNM9ZWNIKaIzm-hLQFvDmdlVYUoV5l8VhX33YJy7Efv_5GP2BTjfA3d-wO3zJnPxdb1X_gWoZ5Yv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1922443998</pqid></control><display><type>article</type><title>Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><creator>He, Z.‐H. ; He, W.‐R. ; Wu, L.‐L. ; Zhao, C. ; Peng, N.‐F. ; Ahir, B.‐K. ; Lu, C.‐Y.</creator><creatorcontrib>He, Z.‐H. ; He, W.‐R. ; Wu, L.‐L. ; Zhao, C. ; Peng, N.‐F. ; Ahir, B.‐K. ; Lu, C.‐Y.</creatorcontrib><description>Linked Content
This article is linked to Bock et al and Bantel et al papers. To view these articles visit https://doi.org/10.1111/apt.13578 and https://doi.org/10.1111/apt.13826.</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.13820</identifier><identifier>PMID: 27910148</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Cytokeratin ; Hepatocellular carcinoma</subject><ispartof>Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.183-184</ispartof><rights>2016 John Wiley & Sons Ltd</rights><rights>Copyright © 2017 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3880-6a03c9608d6ee4e1a63ad7a97f4cadf973082fc1ddb8e3fefbe33e1b7958a24f3</citedby><cites>FETCH-LOGICAL-c3880-6a03c9608d6ee4e1a63ad7a97f4cadf973082fc1ddb8e3fefbe33e1b7958a24f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fapt.13820$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fapt.13820$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,1430,27911,27912,45561,45562,46396,46820</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27910148$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>He, Z.‐H.</creatorcontrib><creatorcontrib>He, W.‐R.</creatorcontrib><creatorcontrib>Wu, L.‐L.</creatorcontrib><creatorcontrib>Zhao, C.</creatorcontrib><creatorcontrib>Peng, N.‐F.</creatorcontrib><creatorcontrib>Ahir, B.‐K.</creatorcontrib><creatorcontrib>Lu, C.‐Y.</creatorcontrib><title>Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization</title><title>Alimentary pharmacology & therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Linked Content
This article is linked to Bock et al and Bantel et al papers. To view these articles visit https://doi.org/10.1111/apt.13578 and https://doi.org/10.1111/apt.13826.</description><subject>Cytokeratin</subject><subject>Hepatocellular carcinoma</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kc1u1DAURi3Uig6FBS-ALHVDF2n9k0lsdlVFAWmkshjW1o1zTV2SeLAdVcOKR-AZ-yR4mJZFpXpj6_ro6Or7CHnL2Rkv5xw2-YxLJdgLsuCyWVaCyeaALJhodCUUl0fkVUq3jLGmZeIlORKt5ozXakHyCnPG-IHabQ4_MEL20_3vP1xRSBRo58MIscxpcPQGN5CDxWGYB4jUQrR-Kv804veIKfkwUXDFRnOEKUEsTw8DtTc4Bhy7MPhfxR-m1-TQwZDwzcN9TL5dfVxffq5W15--XF6sKiuVYlUDTFrdMNU3iDVyaCT0LejW1RZ6p1vJlHCW932nUDp0HUqJvGv1UoGonTwm7_feTQw_Z0zZjD7t9ocJw5wMV_VS8bakUtCTJ-htmONUtjNcC1HXUmtVqNM9ZWNIKaIzm-hLQFvDmdlVYUoV5l8VhX33YJy7Efv_5GP2BTjfA3d-wO3zJnPxdb1X_gWoZ5Yv</recordid><startdate>201701</startdate><enddate>201701</enddate><creator>He, Z.‐H.</creator><creator>He, W.‐R.</creator><creator>Wu, L.‐L.</creator><creator>Zhao, C.</creator><creator>Peng, N.‐F.</creator><creator>Ahir, B.‐K.</creator><creator>Lu, C.‐Y.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>201701</creationdate><title>Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization</title><author>He, Z.‐H. ; He, W.‐R. ; Wu, L.‐L. ; Zhao, C. ; Peng, N.‐F. ; Ahir, B.‐K. ; Lu, C.‐Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3880-6a03c9608d6ee4e1a63ad7a97f4cadf973082fc1ddb8e3fefbe33e1b7958a24f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Cytokeratin</topic><topic>Hepatocellular carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>He, Z.‐H.</creatorcontrib><creatorcontrib>He, W.‐R.</creatorcontrib><creatorcontrib>Wu, L.‐L.</creatorcontrib><creatorcontrib>Zhao, C.</creatorcontrib><creatorcontrib>Peng, N.‐F.</creatorcontrib><creatorcontrib>Ahir, B.‐K.</creatorcontrib><creatorcontrib>Lu, C.‐Y.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology & therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Z.‐H.</au><au>He, W.‐R.</au><au>Wu, L.‐L.</au><au>Zhao, C.</au><au>Peng, N.‐F.</au><au>Ahir, B.‐K.</au><au>Lu, C.‐Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization</atitle><jtitle>Alimentary pharmacology & therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2017-01</date><risdate>2017</risdate><volume>45</volume><issue>1</issue><spage>183</spage><epage>184</epage><pages>183-184</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>Linked Content
This article is linked to Bock et al and Bantel et al papers. To view these articles visit https://doi.org/10.1111/apt.13578 and https://doi.org/10.1111/apt.13826.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>27910148</pmid><doi>10.1111/apt.13820</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0269-2813 |
ispartof | Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.183-184 |
issn | 0269-2813 1365-2036 |
language | eng |
recordid | cdi_proquest_miscellaneous_1845817067 |
source | Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content |
subjects | Cytokeratin Hepatocellular carcinoma |
title | Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T16%3A56%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter:%20cytokeratin%E2%80%9018%20as%20a%20biomarker%20of%20hepatocellular%20carcinoma%20regression%20after%20transarterial%20chemoembolization&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=He,%20Z.%E2%80%90H.&rft.date=2017-01&rft.volume=45&rft.issue=1&rft.spage=183&rft.epage=184&rft.pages=183-184&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.13820&rft_dat=%3Cproquest_cross%3E1922443998%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1922443998&rft_id=info:pmid/27910148&rfr_iscdi=true |